| Aetna | Infectious Diseases: Selected Tests | 2025-06-06 |
| Aetna | Avacincaptad Pegol (Izervay) | 2025-06-06 |
| Medical Mutual | Margenza® (margetuximab-cmkb) (Intravenous) | 2025-06-05 |
| Medical Mutual | Zevaskyn™ (prademagene zamikeracel) (Topical) | 2025-06-05 |
| Medicare Palmetto | Billing and Coding: Additional Claim Documentation Requirements for Not Otherwise Classified (NOC) Drugs and Biological Products with Specific FDA Label Indications (54880) | 2025-06-05 |
| Aetna | External Counterpulsation (ECP) | 2025-06-04 |
| Medical Mutual | Biomarkers for Myocardial Infarction and Chronic Heart Failure | 2025-06-04 |
| Medical Mutual | Cardiovascular Disease Risk Assessment | 2025-06-04 |
| Medical Mutual | Coronavirus Testing in the Outpatient Setting | 2025-06-04 |
| Medical Mutual | Folate Testing | 2025-06-04 |